In contrast to the fast growing knowledge about the acti- pressing signals. One major candidate for growth arrest of nor-
Introduction transduced through two receptors, type I and type II, which function as a heteromeric complex and are modulated by the Early B lymphopoiesis is characterized by the coordinate regumembrane proteoglycan betaglycan. 19, 20 Regulation of cell lation of proliferation, differentiation and death of B cell pregrowth by TGF-␤ is associated with interruption of cell cycle cursors. A critical misbalance of proliferative and inhibitory progression to the S-phase by blocking late G1 events such as growth signals leads to uncontrolled expansion of malignant the phosphorylation of the retinoblastoma (Rb) protein; 21 via blasts in B cell precursor-ALL (BCP-ALL). An essential element feedback the active phosphorylated Rb inhibits its own phosfor the stimulation of normal and leukemic pre-B cells is the phorylation by activating the expression of the TGF-␤ 2 gene stromal microenvironment. Normal fetal pre-B cells survive through the transcription factor ATF-2. 22 TGF-␤ also directly for several weeks on bone marrow stromal cells with an up to inhibits normal and leukemic hematopoietic cells. It antagon-13-fold cell expansion in vitro.
1,2 Stromal cells also efficiently izes the SCF-induced proliferation of hematopoietic progeniprevent apoptotic cell death of leukemic pre-B cells in vitro. 3 tor cells. 23 Cell growth of myelogenous leukemic cell lines is In vitro studies have shown that the critical direct cell-cell decreased through reduction of the SCF-induced transcription contact between normal or leukemic pre-B cells and stromal of the c-jun gene. 24 In B lymphopoiesis, TGF-␤ functions as cells is mediated by adhesion via VLA-4 (CD49d/CD29)-autocrine growth signal of mature B cells with inhibition of VCAM-1 interaction. 4, 5 The stimulation by bone marrow cell proliferation and Ig secretion of activated B cells. 25 It stromal cells and their prolonged survival in the stromal inhibits normal human pre-B cells by blocking IL-7 induced microenvironment in vitro is caused by an efficient blockage pre-B cell stimulation. 26 The aim of our study was to analyze of apoptosis correlating with an enhanced expression of the the effect of TGF-␤ on cell survival and apoptosis of leukemic bcl-2 protein. 6 In addition, cell proliferation of B cell precurand normal B cell precursors in a feeder-dependent sors is regulated by the growth promoting cytokines IL-3, 7, 8 coculture system. IL-7 8, 9 and other soluble B cell growth factors. 10, 11 Recent data also suggest a role of the FLT 3 ligand in the differentiation of primitive B cell precursors in mice. 12 Another activation pathMaterials and methods way of normal and leukemic pre-B cells is mediated through the CD40 antigen and its interaction with the CD40 ligand Human B cell precursors gp39. 13, 14 Mononuclear bone marrow cells of 25 patients with the diagnosis of common ALL were isolated by Ficoll density gradient Propidium iodide (PI) staining with a purity Ͼ98% according to their lymphoid scatter profile and positivity for CD10 and CD19.
PI staining was performed as previously described. 28 Briefly, 5 × 10 4 leukemic BCP or 1 × 10 4 normal BCP were washed in PBS once and gently mixed with 1.5 ml hypotonic fluochrome solution consisting of 50 g PI/ml (Sigma, Deisenhofen,
Feeder cells
Germany) in 0.1% Triton-X (Sigma) and 0.1% sodium citrate. Cells were incubated overnight in the dark at 4°C and ana-C58 was subcloned from the L929 murine fibroblast cell line by limiting dilution assay. This subclone stimulates the human lyzed on a FACScan (Becton Dickinson) equipped with a 488 nm argon laser. Acquisition was performed at a flow rate leukemic pre-cell line BLIN-1 and was selected as a substitute feeder for human bone marrow stromal cells. 15 Cells were lower than 200 nuclei/second. Nuclei (5000) were measured per sample. Analysis was performed using FACS research grown to confluency in 24-well plates and were irradiated with 40 Gy before coculture. Human bone marrow stromal software. Apoptosis was quantified by measuring signals in the hypodiploid region, excluding cell debris of low red fluorcells were isolated from the mononuclear cell fraction of bone marrow aspirates, obtained from patients with non-hematoescence (logarithmic scale). In cell cycle analysis the relative number of cells in the different phases were assessed by flulogical disease.
orescence intensity (linear scale). Histograms were smoothed five times for presentation in the figures.
Coculture systems
Leukemic B cell precursors were seeded on irradiated conflu-RNA preparation, cDNA synthesis and RT-PCR ent C58 feeder layers. Cells were cocultured at 37°C and 5% CO 2 in RPMI 1640 (Gibco, Eggenstein, Germany) with 10% Total cellular RNA was extracted by guanidiniumthiocyanate-mediated lysis. 29 RNA concentration and purity FCS (Hyclone, Logan, UT, Germany). Leukemic enriched BCP were cultured with 1 × 10 6 /ml and highly purified leukemic was measured by absorbance at 260 nm and 280 nm and by agarose gel electrophoresis. cDNA was prepared by reverse BCP with 5 × 10 5 cells/ml on the feeder cells. The phenotype of the surviving cells was confirmed by staining with antitranscription at 37°C for 2 h in a 30 l reaction mixture containing 4 g RNA, 2 g of oligo(dT 21 ) primer (PCR-mate syn-CD10-FITC and anti-CD19-PE (Becton Dickinson) at day 6. In all samples surviving cells were CD10/CD19 positive. BCP thesizer; ABS, Foster City, CA, USA), 25 mm dNTP (Pharmacia, Freiburg, Germany) and 300 U of M-MLV-RT were cultured with 10 ng/ml TGF-␤ 1 (Amersham, Braunschweig, Germany). The anti-TGF-␤ mAb (Genzyme, (Gibco, BRL). The transcription reaction was terminated by heating the samples at 95°C for 10 min. Russelsheim, Germany) or an unrelated isotype-matched mouse control antibody (R&D Systems, Wiesbaden, Germany)
The integrity of RNA and oligo(dT)-synthesized cDNA was first confirmed by analysis of ␤-actin mRNA transcription by was used in a concentration of 100 g/ml. IL-7 (Genzyme) was used at 10 ng/ml. Normal pre-B cells were cocultured RT-PCR. In all samples tested the expected ␤-actin amplification product of 658 bp was seen. with human bone marrow stromal cells with a concentration of 1 × 10 5 cells/ml. The PCR reaction was performed in a total volume of 50 l consisting of 20 pmol of each primer, 10 mm of dNTP (Pharmacia), 5 U of Taq polymerase (Gibco) and 2 mm MgCl 2 (Gibco). The following primers for TGF-␤ 1 were used:
Proliferation assays 5Ј primer 5Ј-GCCCTGGACACCAACTATTGC-3Ј; 3Ј primer 5Ј-GCTGCACTTGCAGGAGCGCAC-3Ј as published preViability of leukemic BCP was assessed by trypan blue assay on days 2, 4 and 6. Data represent the mean of duplicates.
viously. 30 The amplification profile involved preincubation at 94°C for 6 min, 15 cycles of denaturation at 94°C for 0.5 min, annealing at 65°C for 1 min and extension at 72°C for 0.5 min, followed by 20 cycles with identical denaturation Flow cytometry and elongation steps, but with annealing at 60°C for 1 min. The PCR was performed in a UNO thermoblock thermocycler The following mouse anti-human monoclonal antibodies were used: anti-CD10-FITC and anti-CD19-PE (Becton Dickinson).
(Biometra, Goettingen, Germany). The reaction was terminated with final extension for 6 min. The amplification products Cell surface staining was performed according to established procedures and samples were analyzed with a FACScan were separated by electrophoresis on a 1.5% agarose gel at 100V for 1 h and visualized by ethidium bromide staining. (Becton Dickinson). Briefly, 5 × 10 4 to 1 × 10 5 cells were Statistics
TGF-␤ induces apoptosis of leukemic B cell precursors
Survival and apoptosis of leukemic BCP were statistically Mononuclear cells of bone marrow samples from eight tested using the Student's t-test for matched pairs (PC Statistik patients with cALL and one patient with pre-pre-B ALL with 2.1 software; TopSoft, Hannover, Germany). Differences with у70% leukemic blasts were cultured on C58 fibroblasts alone P values р0.05 were considered statistically significant.
or on the murine feeder cells plus TGF-␤ (10 ng/ml). Apoptosis was quantified by PI staining on day 4 or on day 2 in one sample. In the control, the mean percentage of programmed Results cell death was 38% (5-74). With TGF-␤ a mean of 47% (7-83) of the cells died by apoptosis; programmed cell death was TGF-␤ reduces cell viability of leukemic B cell enhanced in seven of nine samples with a mean increase of precursors 24% (data not shown). The difference of apoptosis was statistically significant (P = 0.039). First, gradient isolated mononuclear cells from bone marrow TGF-␤ also induced apoptosis in highly purified leukemic aspirates of eight patients with cALL and two patients with pre-B cells. FACS isolated leukemic pre-B cells of 10 bone pre-pre-B ALL were analyzed for the cytotoxic effect of TGFmarrow samples from patients with the diagnosis cALL were ␤ on leukemic B cell precursors. The relative content of cultured on C58 alone or on C58 plus TGF-␤ (10 ng/ml) for CD10 + /CD19 + leukemic blasts was 70-90%. The subclone 2 days. Leukemic pre-B cells showed a mean of 38% (15-80) C58 from the murine fibroblast cell line L929 served as feeder apoptotic cell death on the murine feeder cells, whereas 61% cell. 10
6 Cells/ml (1 × 10 6 ) were cultured on C58 alone or on (14-84) of the pre-B cells died by apoptosis with TGF-␤. The C58 plus TGF-␤ (10 ng/ml) for 4 days or in two samples for 2 cytokine increased programmed cell death in eight of 10 days. In the control cell number declined rapidly to samples by a mean of 70%, whereas sample Nos 8 and 13 29.4 × 10 4 /ml surviving cells with a relative survival rate rangshowed no increase in apoptosis (Figure 2 ). The difference of ing from 6 to 85% of the initial cell number. TGF-␤ further apoptosis was statistically significant (P = 0.0028). reduced cell viability in 10 of 10 samples with a mean reduction of 53% (30-87) to a mean of 15.4 × 10 4 /ml surviving cells (data not shown). The difference in survival was statInduction of apoptosis is blocked by anti-TGF-␤ mAb istically significant (P = 0.0017).
Results were confirmed with highly purified leukemic pre-B Highly purified leukemic pre-B cells from five patients with cells. Fourteen samples of FACS isolated leukemic pre-B cells cALL were cultured on C58 alone (control), on C58 plus TGF-(purity Ͼ98%) of patients with cALL were cultured on C58 ␤ or on C58 plus TGF-␤ plus anti-TGF-␤ mAb. Apoptotic cell alone (control) or on C58 plus TGF-␤ (10 ng/ml) for 2 days.
death was assessed by PI staining on day 2. TGF-␤ enhanced The initial cell number was 5 × 10 5 /ml. Three samples apoptosis in four of five samples with a mean increase of 67% (Nos 1, 3, 7) showed an increase of viable cells with 5.6 × 10 5 , . In sample No. 13, with a high spontaneous apop-8.8 × 10 5 and 6.6 × 10 5 cells/ml, respectively. In 11 samples totic death rate of 80%, TGF-␤ had no additional effect on the number of viable leukemic pre-B cells declined with a apoptosis (Figure 3 ). Anti-TGF-␤ mAb completely blocked relative survival rate of 42% (12-80) of the initial cell number TGF-␤-induced apoptosis in all samples. In sample 12, 32% to a mean of 21 × 10 4 /ml surviving cells. TGF-␤ led to a loss (±1.8) of the leukemic pre-B cells died by apoptosis in the of cell viability in 13 of 14 samples (with the exception of control vs 68% (±3.1) with TGF-␤ and 31% with TGF-␤ plus sample No. 6) with a mean reduction of 53% (25-100) to anti-TGF-␤, in sample No. 14 30% (±9.7) in the control vs a mean of 16.6 × 10 4 /ml surviving cells compared to 83% (±0.1) with TGF-␤ and 22% (±3.3) with TGF-␤ plus anti-31.5 × 10 4 /ml surviving cells in the control (Figure 1 ). The difbody. In two samples leukemic pre-B cells revealed a signifiference in survival was statistically significant (P = 0.0001).
cant lower apoptotic death rate with TGF-␤ and anti-TGF-␤ mAb compared to the control: in sample 13, 80% (±14.5) of 5 × 10 5 highly purified leukemic pre-B cells of 10 patients with cALL were cultured on irradiated C58 fibroblasts in patients with cALL were cultured on irradiated C58 fibroblasts in medium alone (control) or with TGF-␤ (10 ng/ml) for 2 days. Cell medium alone (control) or with TGF-␤ (10 ng/ml) for 2 days. Apoptosis was quantified by PI staining. Data represent the mean of viability was assessed by trypan blue exclusion. Data represent the mean of two independent measurements. two independent measurements. 49% with IL-7. In three samples IL-7 could not antagonize the induction of apoptosis by TGF-␤: in sample 3, 74% (±1.9) of cells/ml (±1.5). Cell cycle analysis showed suppression of Sphase from 44.3% (±1.5) in the control to 31% (±1.7) and the cells died by apoptosis in the control, 83% (±2.8) with TGF-␤, 68% (±2.4) with IL-7 and 85% (±2) with TGF-␤ plus induction of G0/G1 arrest from 44.1% (±1.9) to the control and 69.1% (±0.85) by TGF-␤ on day 4. Anti-TGF-␤ mAb com-IL-7; in sample 11, 61% (±1.3) apoptosis was observed in the control, 64% (±0.3) with TGF-␤, 42% (±4) with IL-7 and 67% pletely blocked the effect of the cytokine, whereas the unrelated matched isotype control antibody did not effect growth (±3.3) with TGF-␤ plus IL-7; in sample 15, 57% (±3.2) of the cells died by apoptosis in the control, 75% (±1.7) with TGFinhibition by TGF-␤ (Table 1) .
␤, 48% (±2.3) with IL-7 and 74.5% (±2.3) with TGF-␤ plus IL-7. In sample 1, IL-7 completely blocked the effect of TGF-␤ with an apoptotic cell fraction of 52% (±4.6) in the control, TGF-␤ does not reduce bcl-2 expression 72% (±6.1) with TGF-␤, 37% (±3.0) with IL-7 and 34% (±0.8) with TGF-␤ plus IL-7 ( Figure 5 ). In sample Nos 3, 4, 7, 12 and 14 highly purified leukemic pre-B cells were analyzed for bcl-2 expression by anti-bcl-2 mAb. Leukemic blasts were cultured on C58 alone (control) or with TGF-␤ (10 ng/ml) for 2 days. In all samples TGF-␤ did TGF-␤ induces apoptosis of normal pre-B cells not modify the bcl-2 level in the leukemic cells (Figure 4) .
To test the inhibitory effect of TGF-␤ on normal pre-B cells, highly purified BCP were cocultured on human bone marrow stromal cells to reduce spontaneous apoptosis. Stromal cells
Influence of IL-7 on induction of apoptosis by TGF-␤ in leukemic BCP
reduced programmed cell death from 80% (±8) in the controls to 28% (±13) (data not shown). Highly purified normal pre-B cells of six samples were analyzed for growth inhibition by The effect of IL-7 on induction of apoptosis by TGF-␤ was tested in four samples of enriched leukemic BCP on day 4.
TGF-␤. Pre-B cells (1 × 10 5 ) were cultured on human bone /ml mononuclear cells of four patients with the diagnosis of B cell precursor ALL were cultured on C58 fibroblasts in medium alone (control), with TGF-␤ (10 ng/ml), IL-7 (10 ng/ml) or with IL-7 + TGF-␤ for 4 days. Apoptosis was measured by PI staining. Data represent the mean of three independent measurements. in B cell precursor ALL (BCP-ALL), the precise regulatory mechanisms, which lead to the infinite cell proliferation is not In order to test endogenous TGF-␤ production by leukemic well understood. Growth inhibitory cytokines especially, pre-B cells, cytokine gene transcription was analyzed in the which are thought to play an important role in antagonizing leukemic pre-B cell line BLIN-1 by RT-PCR (Figure 7) . BLINunphysiological growth stimuli in BCP-ALL, are only poorly 1 were cultured in medium alone and RT-PCR was performed analyzed. One reason for this is the rapid death of the leuusing cells in the log phase of proliferation. The Burkitt cell kemic cell population ex vivo, which hampers the analysis line Raji served as positive control. As shown in Figure 7 the of growth inhibition. This can be overcome by using feeder-RT-PCR did not show the typical 335 bp amplification product dependent coculture systems, which block efficiently the for TGF-␤ 1 for BLIN-1. In addition, anti-TGF-␤ mAb did not apoptosis of the B cell precursors. 2,3 The use of this coculture enhance cell viability or reduce apoptosis of highly purified technique led to the identification of IL-4 and IFN-␣ as inhibileukemic pre-B cells cultured in medium alone: in sample tory cytokines of leukemic BCP. 16, 17 A disadvantage of this No. 15, 13 × 10 4 cells/ml (±1.7) of the highly purified leucoculture system, which depends on the heterogenous feeder kemic pre-B cells survived in the control, compared to cell population of human bone marrow stroma, is the com-15 × 10 4 cells/ml (±3.6) with anti-TGF-␤ mAb and 14 × 10 4 plexity of the in vitro assay. Therefore, we used a subclone of cells/ml (±2) with the isotype matched control antibody; the well defined murine fibroblast cell line L929 as feeder apoptosis was 58% ± 0.4 in the control, 57% ± 1.1 with anticells for the analysis of growth inhibition, which was shown TGF-␤ mAb and 59% ± 1.3 with the isotype matched control to substitute for human bone marrow stromal cells in stimuantibody (data not shown).
lation of leukemic pre-B cells. 15 In contrast to BLIN-1 cells, high transcription of TGF-␤ was One major candidate for an inhibitory growth factor for B detected in C58 cells by RT-PCR (Figure 7) . cell precursors is TGF-␤. TGF-␤ is a potent growth inhibitory cytokine for multiple cell types of epithelial and hematopoietic origin. 18 So far, the influence of TGF-␤ on early B lymphopoiesis has not been extensively studied. Our data show, that in leukemic B cell precursors TGF-␤ reduced cell viability and enhanced apoptotic cell death. This effect was seen in the samples with Ͼ70% leukemic blasts as well as in the samples with a Ͼ98% purity of leukemic B cell precursors. This effect was not due to a toxic effect of TGF-␤ on the fibroblasts, since cell viability of the feeder cells were identical in TGF-␤ treated cocultures and in the controls. The effect of TGF-␤ was not restricted to leukemic BCP: also, normal pre-B cells were inhibited by the cytokine with an increased apoptotic death rate. Our identification of TGF-␤ as an inhibitory cytokine of leukemic BCP is confirmed by recent data, kine. 31 The precise mechanism of growth inhibition of B cell precursors in a stromal microenvironment is not known. TGFor is itself presented in a biologically efficient form by extracellular matrix components of the feeder cells as shown for ␤ decreases the expression of VCAM-1 on bone marrow stromal cells. This could lead to an interruption of the adhesion other cytokines.
34-36
Our data show that TGF-␤ also induces apoptosis in normal of B cell precursors to stromal cells via the VLA-4-VCAM-1 interaction, which is critical for survival of normal and leuhighly purified BCP. Thus, leukemic B cell precursors retain their sensitivity to TGF-␤. This agrees with data about maligkemic B cell precursors. 4, 5, 32 Another potential mechanism of TGF-␤ for pre-B cell inhibition in the bone marrow micronant myeloid progenitors in AML and CML, which -as well as their physiological counterparts -are inhibited by TGFenvironment is the reduction of pre-B cell growth factor production of stromal cells and the repression of surface ␤. 40, 41 In contrast, malignant cells of epithelial origin often characteristically lose their responsiveness to the cytokine due expression of the corresponding cytokine receptors. This was described in long-term bone marrow cultures (LTBMC), in to mutations and subsequent inactivation of the type II TGF-␤ receptor. 42 which TGF-␤ inhibits proliferation of hematopoietic progenitor cells by repressing the stem cell factor gene transcription Programmed cell death is regulated by the proto-oncogene bcl-2 and bcl-2-related proteins. 43, 44 The induction of in the stromal cells and reducing c-kit expression of the stem cells through decrease of the stability of the c-kit transcript. 23 apoptosis by TGF-␤ did not correlate with a reduced expression of the bcl-2 protein. All five samples showed an Recent data describe the downregulation of the IL-7 secretion of human bone marrow stromal cells by TGF-␤. 33 The cytoidentical expression of bcl-2 with or without TGF-␤. This is in contrast to data in B-CLL, where the growth inhibition by kine can suppress the surface receptor expression of the pre-B cell growth factor IL-3 on hematopoietic progenitor cells in IL-10 correlates with a down-regulation of bcl-2. 45 Our experiments with a limited number of samples show that the the mouse, 34 but there are no data about modulation of IL-3 receptor surface expression on B cell precursors or the influinhibitory effect of TGF-␤ on leukemic blasts can be antagonized by the pre-B cell growth factor IL-7. This agrees with ence of TGF-␤ on the surface expression of other cytokine receptors as for example IL-7R. Another possibility is the recent data in the human system, in which growth inhibition of normal TdT + lymphoid precursor colonies by TGF-␤ was modulation of the binding of growth factors to extracellular matrix (ECM) components. In the mouse GM-CSF and IL-3 are completely abolished by IL-7. In this system, the effect of IL-7 was dependent on the dose of TGF-␤ with no reversion of bound and presented in a biologically active form by the ECM, 35 ,36 whereas IL-7 loses its growth-promoting effect by growth inhibition at high TGF-␤ concentrations. 33 This could explain why IL-7 had no effect on TGF-␤ induced growth inhibinding to heparan sulphate. 32,37 Thus, TGF-␤ could indirectly inhibit B cell precursors by blocking binding of IL-3 or bition in the other three samples tested. Vice versa, in vitro data about normal pre-B cells in the mouse showed that ILinducing binding of IL-7 to heparan sulphate.
We observed an interindividual heterogeneity of the TGF-7-induced proliferation is completely blocked by TGF-␤.
46
Our analysis identifies TGF-␤ 1 as a potent growth inhibi-␤ response, which suggests that at least some of the leukemic blast populations can reduce the TGF-␤ effect, possibly due tory cytokine of leukemic B cell precursors in the human system. The identification and characterization of negative to downregulation of TGF-␤ receptor expression.
The effect of TGF-␤ was specifically blocked by anti-TGFgrowth regulators and their functional counterparts may have particular relevance for the understanding of the concerted ␤ mAb. In two samples the leukemic pre-B cells revealed a higher cell viability with TGF-␤ and the mAb as in the control.
action of growth inhibitory and growth promoting mediators in early B lymphopoiesis. It may help to characterize the fatal TGF-␤ is a highly species-conserved polypeptide with crossreactivity between the murine and human system. 18, 38 The imbalance in the regulation of cell death and cell proliferation in BCP-ALL and opens new perspectives for the development growth advantage of the leukemic B cell precursors cocultured with TGF-␤ plus anti-TGF-␤ mA is explained by the of innovative therapeutic strategies. additional neutralization of endogenous TGF-␤ produced by the murine feeder cells, because we showed that the murine References feeder cell C58 is highly positive for TGF-␤ transcripts by RT-PCR. This effect of anti-TGF-␤ mAb was also shown for hema- ␤ protein production in leukemic human pre-B cell lines. TGF-␤ synergizes with cytokines produced by the feeder cells
